TSE:TOS - TSO3 Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$0.46 -0.01 (-2.13 %) (As of 11/15/2018 07:52 AM ET)Previous CloseC$0.47Today's RangeC$0.43 - C$0.4752-Week RangeC$0.39 - C$2.83Volume153,300 shsAverage Volume175,457 shsMarket CapitalizationN/AP/E Ratio-3.57Dividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email TSO3 Inc. engages in the research, development, production, maintenance, sale, and licensing of sterilization processes, related consumable supplies, and accessories for heat and moisture sensitive medical devices worldwide. Its principal product is the STERIZONE VP4 sterilizer, a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide and ozone that is marketed in Canada and the United States. The company also develops and sells the STERIZONE 125L+ sterilizer, which is designed for terminal sterilization of heat and moisture sensitive medical devices, and is intended for the reprocessing of general instruments, rigid channel instruments, and single/multi-channel rigid endoscopes, as well as short and long single/multi-channel flexible endoscopes. In addition, it provides product development services to medical device manufacturers and others that include hydrogen peroxide and ozone sterilization validation, compatibility testing, medical devices cleaning method development, and medical packaging compatibility verification services. The company was founded in 1998 and is headquartered in Quebec, Canada. Receive TOS News and Ratings via Email Sign-up to receive the latest news and ratings for TOS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange TSE Industry Medical Instruments & Supplies Sub-IndustryN/A SectorMedical Current SymbolTSE:TOS Previous Symbol CUSIPN/A Webwww.tso3.com Phone+1-418-6510003 Debt Debt-to-Equity Ratio415.90 Current Ratio9.07 Quick Ratio7.26 Price-To-Earnings Trailing P/E Ratio-3.57 Forward P/E Ratio-6.57 P/E GrowthN/A Sales & Book Value Annual SalesC$7.19 million Price / Sales5.94 Cash FlowC$0.17 per share Price / Cash2.66 Book ValueC$0.05 per share Price / Book10.22 Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees69 Outstanding Shares92,891,000Market CapC$0.00 OptionableNot Optionable TSO3 (TSE:TOS) Frequently Asked Questions What is TSO3's stock symbol? TSO3 trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TOS." When is TSO3's next earnings date? TSO3 is scheduled to release their next quarterly earnings announcement on Tuesday, March 19th 2019. View Earnings Estimates for TSO3. What price target have analysts set for TOS? 5 brokerages have issued 12-month target prices for TSO3's stock. Their predictions range from C$0.80 to C$2.75. On average, they anticipate TSO3's stock price to reach C$1.58 in the next year. This suggests a possible upside of 243.5% from the stock's current price. View Analyst Price Targets for TSO3. What is the consensus analysts' recommendation for TSO3? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TSO3 in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for TSO3. Has TSO3 been receiving favorable news coverage? Media headlines about TOS stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. TSO3 earned a news impact score of 1.4 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 5.0 out of 10, indicating that recent media coverage is somewhat likely to have an impact on the company's share price in the next few days. Who are some of TSO3's key competitors? Some companies that are related to TSO3 include Advanced Medical Solutions (AMS), Akers Biosciences (AKR), Ansell (ANN), Bovie Medical (BVX), Bovie Medical (BVX), Clover (CLV), CONVATEC Grp PL/ADR (CNVVY), CRH Medical (CRHM), CRH Medical (CRH), Daxor (DXR), Enerplus (ERF), Essilor International Cmgn Gnl D Optq (EI), Gerresheimer (GXI), InfuSystem (INFU) and Iris BioTechnologies (IRSB). Who are TSO3's key executives? TSO3's management team includes the folowing people: Mr. Richard M. Rumble, Pres, CEO & Director (Age 59)Mr. Glen Kayll, Chief Financial Officer (Age 49)Mr. Harold R. Tessman, Chief Operations OfficerDr. Bradley J. Catalone MBA, Ph.D., Chief Scientific OfficerMs. Cindy Clark, Sr. VP of Global Commercialization How do I buy shares of TSO3? Shares of TOS and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is TSO3's stock price today? One share of TOS stock can currently be purchased for approximately C$0.46. What is TSO3's official website? The official website for TSO3 is http://www.tso3.com/. How can I contact TSO3? TSO3's mailing address is 2505 Dalton Ave, QUEBEC, QC G1P 3S5, Canada. The company can be reached via phone at +1-418-6510003. MarketBeat Community Rating for TSO3 (TSE TOS)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 141 (Vote Outperform)Underperform Votes: 138 (Vote Underperform)Total Votes: 279MarketBeat's community ratings are surveys of what our community members think about TSO3 and other stocks. Vote "Outperform" if you believe TOS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TOS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/15/2018 by MarketBeat.com StaffFeatured Article: Can individual investors take part in an IPO?